AstraZeneca bolsters heart and kidney business with $1.8 billion deal with CinCor

AZN shares slip 1% on Monday Farxiga-baxdrostat combination could expand franchise – AZN exec Falling valuations of biotech companies could boost deal-making Jan 9 (Reuters) – AstraZeneca (AZN.L) said on Monday it has reached an agreement to buy U.S. drug developer CinCor Pharma Inc (CINC.O) for up to $1.8 billion to boost its stock of … Read more

Analysis: Nature Accord Gets Funding, Companies Approve, But Barriers Remain

COP15 conference reaches historic agreement to protect nature Business and finance leaders now focus on national rules Concerns about the pace and scale of capital flows to nature MONTREAL, Dec 20 (Reuters) – A landmark agreement to protect nature will put biodiversity on the to-do list for businesses and financial firms – creating bureaucracy but … Read more

GSK’s oncology business suffers another blow with Zejula setback

News follows setback for GSK’s blood cancer drug Blenrep Shares fall nearly 5% in afternoon trading Nov 11 (Reuters) – Britain’s GSK said on Friday it would limit the use of its ovarian cancer drug Zejula in the United States as a second treatment option to ward off cancer in patients whose tumors carry certain … Read more

Wall Street mixed after weak trade data; Tesla drags the Nasdaq

China’s ADRs fall on concerns over the direction of the economy Tesla falls on price cuts in China Activity contracts in the United States in October Indices: Dow up 0.46%, S&P down 0.09%, Nasdaq down 1.19% Oct 24 (Reuters) – U.S. stock indexes were mixed in morning trading on Monday, with the tech-heavy Nasdaq hit … Read more